Skip to main content
. 2021 Sep 1;9(6):1521–1555. doi: 10.1016/j.gendis.2021.08.003

Table 1.

Expression of CHIP in various tumor tissues. Arrow headed (↑) and (↓) indicates up and down-regulation of CHIP.

Year Type of Cancer Number of samples In-vivo study (Yes/No) CHIP Expression Reference
2010 Breast cancer 160 No 375
2011 Breast cancer 183 No 392
Glioma 40 Yes 399
2012 Gastric cancer 53 No 395
2013 Esophageal squamous cell carcinoma 234 No No change 389
Gastric cancer 640 Yes 396
Gallbladder carcinoma 78 No 390
Colorectal cancer 320 No 364
2015 HBV-hepatocellular carcinoma 79 No 400
Human renal cell carcinoma 304 Yes 397
Human renal cancer 12 Yes 342
Gastric cancer 164 No 58
2016 Non-small cell lung cancer 106 Yes 398
Postmenopausal breast cancer 272 No 394
2017 Head and neck cancer 101 Yes 401
2018 Colorectal cancer 93 Yes 402
Prostate cancer 90 No 391
2019 Gastric cancer 100 Yes 361
Breast cancer 128 Yes 393